This study is a clinical study to evaluate the reliability and validity of the cognitive impairment assessment tool.
Early diagnosis and treatment of dementia are particularly important diseases because dementia has not yet been shown to be a fundamental therapeutic agent and has been reported to delay the progress of the disease.
In Oriental medicine, there is no disease name that accurately responds to modern dementia disease. However, the characteristic memory impairment and cognitive dysfunction in dementia, psychological behavior problems, dementia, dementia, amnesia, epilepsy, hunger, )) And so on.
Based on the literature review and the expert opinion survey, the self - diagnosis scale of the dementia diagnosed by four types of divergence such as 气虛, 虚虛, 火 热 and 痰) is established, Reliability evaluation Clinical studies were conducted to confirm validity and reliability.
However, an amendment was made to reflect the results of the clinical study and additional clinical studies were conducted to apply it to mild cognitive impairment other than dementia.
The evaluators of this study should be two study doctors A and B who have studied and practiced enough to understand the purpose of the research evaluation tool, examination and scoring method. In Screening and Visit 1, after the applicant A judges the appropriateness of the selection criteria and the exclusion criterion for the applicants, the oriental medical practitioners A and B respectively implement the evaluation tool for cognitive impairment. The visit 2 is performed within 7 ± 3 days after screening and visit 1, and the oriental doctor A re-examines the cognitive-dysfunctional assessment tool, the diagnostic tool for the diagnosis of dementia, and the Mini-Mental State Examination-Dementia Screening. The subjects are also screened, pulse test, body composition test, Electroencephalography, and brain oxygen saturation test.

Cohort/Group Label

Observation group

Cohort/Group Description

In Screening and Visit 1, after the applicant A judges the appropriateness of the selection criteria and the exclusion criterion for the applicants, the oriental medical practitioners A and B respectively implement the evaluation tool for cognitive impairment. The visit 2 is performed within 7±3 days after screening and visit 1, and the doctor A examines the cognitive dysfunction evaluation tool and the dementia
And the Mini-Mental State Examination-Dementia Screening. The subjects are also screened, pulse test, body composition test, Electroencephalography, and Brain oxygen saturation test.

Not collect nor Archive

Male and female adults aged 45 to under 85 years who visited for cognitive impairment

This study uses non-random sampling method which is one of the widely used sampling methods in clinical studies.
We select all the subjects who satisfy the selection criteria at a specific time interval or patients, and draw a random sample of the participants voluntarily participating in the experiment.
Probabilistic sampling is a time- and cost-intensive method of collecting the entire list of probabilistic probes from the sampling list itself in order to ensure that all members of the population are equally selected. we don't use that method because it is not suitable for extraction method.

Gender

Age

Description

1) Aged 45 to under 85 old, male and female adults
2) Those diagnosed with major or mild neurological dysfunction according to the DSM-5 standard
3) Clinical Dementia Rating 0.5 or 1 person
4) Korean version of the Montreal Cognitive Assessment Below 22 points
5) The caregiver or caregiver who cares for the patient or the patient understands the contents of the questionnaire.
A person
6) If the patient or his / her legal representative voluntarily agrees to the clinical study consent in writing

1) In cases of dementia due to systemic diseases such as endocrine, infection (eg hypothyroidism, thiamin, rain Thymine B12 deficiency, neurosyphilis, human immunodeficiency virus, encephalitis, etc.)
2) Psychiatric disorders diagnosed by The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: schizophrenia, delusional disorder, bipolar disorder Those with a history of major psychiatric disorders such as mental or substance abuse disorders
3) Those with a seriously unstable medical condition (such as clinical laboratory tests, vital signs, etc. By the judgment of the doctor in charge)
4) Malignant tumor patients who were not cured
5) History of head injury that causes loss of consciousness for more than 1 hour
6) History of traumatic brain hemorrhage, brain tumor, subarachnoid hemorrhage
7) Those who are at risk of suicide
8) If the applicant or legal representative does not understand the consent, Occation
9) Those who are not eligible to participate in this clinical study at the discretion of other researchers
10) If you participated in other clinical studies within the first month of the study or during the test period If you plan to participate in other clinical studies

Pattern identification tool for Cognitive Disorders

day 0, day 7

Korean diagnostic tool of dementia

day 7

Pattern identification inventory of Cold, Heat, Deficiency and Excess

day 7

Korean Version of Montreal Cognitive Assessment

Screnning

Korean Version of Expanded Clinical Dementia Rating

Screnning

Neuropsychiatric Inventory–Questionnaire

day 7

Korean Instrumental Activities of Daily Living

day 7

Mini-Mental State Examination-Dementia Screening

day 7

Tongue Diagnosis Examination

day 7

Pulse Diagnosis Examination

day 7

Bioelectrical Impedance Analyzer

day 7

Electroencephalography

day 7

Brain oxygen saturation test

day 7